Affymetrix Sues Illumina Over Gene Detection Patent

Law360, New York (August 5, 2004, 12:00 AM EDT) -- Affymetrix Inc., the leading producer of gene-detection devices, has sued rival Illumina Inc. over patents for a technology used to track genetic differences and to identify which genes are activated in particular types of cells.

The suit, filed in U.S. District Court for the District of Delaware, alleges infringement of six Affymetrix patents, related to aspects of software, hardware and arrays, which are used for DNA sequencing and other purposes.

Affymetrix, which is seeking royalties, said it went to court reluctantly ``after many good-faith efforts to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.